Net sales/ Profits (Consolidated)

Financial Year FY2016 FY2017 FY2018 FY2019 FY2020
Net sales 13,133 12,077 14,440 13,034 11,841
Operating income 361 182 962 454 ▲566
Ordinary profit 397 214 1,032 499 ▲523
Net income attributable to owners of the patent 235 198 692 357 ▲576

Net sales

Operating income

Operating income

Ordinary profit

Ordinary profit

Net income attributable to owners of the patent

Net income

 

Profitability (Consolidated)

(%)
Financial Year FY2016 FY2017 FY2018 FY2019 FY2020
Operating income/Net sales 2.8 1.5 6.7 3.5 ▲4.8
Ratio of ordinary profit to net sales 3.0 1.8 7.1 3.8 ▲4.4
Net income/Net sales 1.8 1.6 4.8 2.7 ▲4.9
1.6 1.4 4.7 2.4 ▲4.0

Operating income/Net sales/Ratio of ordinary profit to net sales /Net income/Net sales

Operating income/Net sales/Ratio of ordinary profit to net sales /Net income/Net sales

Return on stockholders' equity (ROE)

株主資本当期純利益率(ROE)

 

Capital expenditures/ Depreciation/ R&D expenses  (Consolidated)

(Millions of yen)
Financial Year FY2016 FY2017 FY2018 FY2019 FY2020
Capital expenditures 638 254 500 877 1,136
Depreciation 757 777 758 787 824
R&D expenses 1,488 1,465 1,329 1,326 1,476

Capital expenditures/Depreciation/R&D expenses

Capital expenditures/Depreciation/R&D expenses

Update:2021/4/23